POTASSIUM CHLORIDE IN SODIUM CHLORIDE- sodium chloride and potassium chloride solution মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

potassium chloride in sodium chloride- sodium chloride and potassium chloride solution

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - sodium chloride 0.9 g in 100 ml - potassium chloride in 0.9% sodium chloride injection is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. potassium chloride in 0.9% sodium chloride injection is contraindicated in clinical conditions where additives of sodium, potassium or chloride could be clinically detrimental.

SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE injection মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

sodium ferric gluconate complex in sucrose injection

hikma pharmaceuticals usa inc. - sodium ferric gluconate complex (unii: cc9149u2qx) (ferric cation - unii:91o4lml611) - ferric cation 12.5 mg in 1 ml - sodium ferric gluconate complex in sucrose injection is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. sodium ferric gluconate complex in sucrose injection is contraindicated in patients with known hypersensitivity to sodium ferric gluconate or any of its components. reactions have included anaphylaxis [see warnings and precautions (5.1) ]. risk summary parenteral iron administration may be associated with hypersensitivity reactions [see warnings and precautions (5.1) ], which may have serious consequences, such as fetal bradycardia (see clinical considerations ). advise pregnant women of the potential risk to the fetus. available data from postmarketing reports with sodium ferric gluconate complex in sucrose injection use in pregnancy are insufficient to assess the risk of major birth defects and miscarriage. sodium ferric gluconate comple

PREPOPIK- sodium picosulfate, magnesium oxide, and anhydrous citric acid powder, metered মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

prepopik- sodium picosulfate, magnesium oxide, and anhydrous citric acid powder, metered

ferring pharmaceuticals inc. - sodium picosulfate (unii: lr57574hn8) (deacetylbisacodyl - unii:r09078e41y), magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium picosulfate 10 mg in 16.1 g - prepopik® is indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients 9 years of age and older. prepopik is contraindicated in the following conditions: - patients with severe renal impairment (creatinine clearance less than 30 ml/minute) which may result in accumulation of magnesium [see warnings and precautions (5.4)] - gastrointestinal obstruction or ileus [see warnings and precautions (5.6)] - bowel perforation [see warnings and precautions (5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any of the ingredients in prepopik [see adverse reactions (6.2)] risk summary there are no data with prepopik use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in an animal reproduction study, no adverse developmental effects were observed in pregnant rats when sodium picosulfate, magnesium oxide, and anhydrous citric acid were administered orally at doses 1

SODIUM CHLORIDE irrigant মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

sodium chloride irrigant

cardinal health - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37) - sodium chloride 0.9 g in 100 ml

Sodium Chloride 0.3 % w/v and Glucose 3.3% w/v Solution for Infusion BP আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

sodium chloride 0.3 % w/v and glucose 3.3% w/v solution for infusion bp

baxter holding b.v. - sodium chloride; glucose - solution for infusion - 0.3/ 3.3 percent weight/volume - salt solutions; sodium chloride

Sodium Chloride 0.45 % w/v and Glucose 2.5% w/v Solution for Infusion BP আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

sodium chloride 0.45 % w/v and glucose 2.5% w/v solution for infusion bp

baxter holding b.v. - sodium chloride; glucose - solution for infusion - 0.45/2.5 percent weight/volume - salt solutions; sodium chloride

Sodium Chloride 0.45% w/v Solution for Infusion আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

sodium chloride 0.45% w/v solution for infusion

baxter holding b.v. - sodium chloride - solution for infusion - 0.45 percent weight/volume - electrolyte solutions; sodium chloride

Sodium Chloride 0.9 % w/v and Glucose 5% w/v Solution for Infusion BP (Viaflo container) আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

sodium chloride 0.9 % w/v and glucose 5% w/v solution for infusion bp (viaflo container)

baxter holding b.v. - sodium chloride; glucose - solution for infusion - 0.9/5 percent weight/volume - salt solutions; sodium chloride

Sodium Chloride Intravenous Infusion BP 0.9% w/v (viaflex container) আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

sodium chloride intravenous infusion bp 0.9% w/v (viaflex container)

baxter holding b.v. - sodium chloride - solution for infusion - 0.9 percent weight/volume - electrolyte solutions; sodium chloride

Sodium Chloride 0.9 % w/v solution for infusion আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

sodium chloride 0.9 % w/v solution for infusion

fresenius kabi deutschland gmbh - sodium chloride - solution for infusion - 0.9 percent weight/volume - electrolyte solutions; sodium chloride